Article

Pre-determined diversity in resistant fates emerges from homogenous cells after…

medRxiv · 2021 · Goyal, Y.; Dardani, I. P.; Busch, G. T.; Emert, B.; Fingerman, D.; Kaur, A.; Jain, N.; Mellis, I. A.; Li, J.; Kiani, K.; Fane, M. E.; Weeraratna, A. T.; Herlyn, M.; Raj, A.

Key facts

Title Pre-determined diversity in resistant fates emerges from homogenous cells after anti-cancer drug treatment
First author Goyal, Y.; Dardani, I. P.; Busch, G. T.; Emert, B.; Fingerman, D.; Kaur, A.; Jain, N.; Mellis, I. A.; Li, J.; Kiani, K.; Fane, M. E.; Weeraratna, A. T.; Herlyn, M.; Raj, A.
Journal medRxiv
Published Dec 9, 2021
DOI 10.1101/2021.12.08.471833
Devices mentioned BK110039, DEN000008, K022086, K103302, K952425, K952466
Product codes mentioned JCI, JHN, JIX, JJH, KIT, LYC, NPM, MVU, NDS, NJT, OOI, PFF and 2 more

At a glance

  • 1–9 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature